Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Baselga

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
British Journal of Cancer|October 23, 2008
Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell linesE Vilar, M Scaltriti, J Balmaña, et al.
International Journal of Clinical Practice|January 16, 2009
Prognostic factors in the diagnostic work-up of cancer patients in an internal medicine department: does age matter?E Domingo, J M Suriñach, J Murillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2014
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRAS M Swain, J Baselga, D Miles, et al.
Cancer|November 20, 1997
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinomaJ Bellmunt, A Ribas, N Eres, et al.
Oncogene|October 18, 2016
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependenceC Yang, Z Li, T Bhatt, et al.
Cancer Investigation|August 29, 2002
Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancerJ Bellmunt, J Cos, R Clèries, et al.
The Journal of Clinical Investigation|February 12, 1998
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transportersD B Agus, S S Gambhir, W M Pardridge, et al.
Cancer Research|May 15, 1993
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lungV Rusch, J Baselga, C Cordon-Cardo, et al.
Revista Espanola De Anestesiologia Y Reanimacion|January 1, 1984
[Anesthetic problems in hip replacements using the uncemented Lord type universal madreporic prosthesis and its comparison with cemented ones]G Tera Bueno, A Lajara Montell, A Muñoz Jiménez, et al.
European Journal of Immunology|October 10, 2001
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cellsW E Carson, R Parihar, M J Lindemann, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
British Journal of Cancer|October 23, 2008
Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell linesE Vilar, M Scaltriti, J Balmaña, et al.
International Journal of Clinical Practice|January 16, 2009
Prognostic factors in the diagnostic work-up of cancer patients in an internal medicine department: does age matter?E Domingo, J M Suriñach, J Murillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2014
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRAS M Swain, J Baselga, D Miles, et al.
Cancer|November 20, 1997
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinomaJ Bellmunt, A Ribas, N Eres, et al.
Oncogene|October 18, 2016
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependenceC Yang, Z Li, T Bhatt, et al.
Cancer Investigation|August 29, 2002
Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancerJ Bellmunt, J Cos, R Clèries, et al.
The Journal of Clinical Investigation|February 12, 1998
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transportersD B Agus, S S Gambhir, W M Pardridge, et al.
Cancer Research|May 15, 1993
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lungV Rusch, J Baselga, C Cordon-Cardo, et al.
Revista Espanola De Anestesiologia Y Reanimacion|January 1, 1984
[Anesthetic problems in hip replacements using the uncemented Lord type universal madreporic prosthesis and its comparison with cemented ones]G Tera Bueno, A Lajara Montell, A Muñoz Jiménez, et al.
European Journal of Immunology|October 10, 2001
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cellsW E Carson, R Parihar, M J Lindemann, et al.
Pageof 17